https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-payable-other-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accounts-receivable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accrued-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accumulated-depreciation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-cash-and-equivalents https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-current-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-current-liabilities-accounts-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-other-noncurrent-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquired-property-plant-and-equipment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquisition-acquisition-of-less-than-100-percent-noncontrolling-interest-fair-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquisition-step-acquisition-equity-interest-in-acquiree-percentage https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/acquisitions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/activist-13d-13g-form-schedule-13g https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/additional-paid-in-capital https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/additions-to-noncurrent-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/adjustment-for-amortization https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/advertising-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/amended-reports-10-k https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/amended-reports-10-q https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/amortization https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/aoci https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/asset-impairment-charges https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-gross-unrealized-gain-loss-1 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/available-for-sale-sold-at-par https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/bank-overdrafts https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/basic-shares https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisition-purchase-price-allocation-liabilities-assumed https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisition-purchase-price-allocation-noncontrolling-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/buyback-authorization-remaining https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/buybacks-payments-for-repurchase-of-warrants https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-expenditures https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-lease-obligations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-income-statement-amortization-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-acquired-in-excess-of-payments-to-acquire-business https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-and-equivalents https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-change https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cash-uninsured-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/common-stock-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/compensation-and-benefits-trust https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/comprehensive-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/construction-and-development-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/contractual-obligation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/convertible-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/convertible-notes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cost-method-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cost-method-investments-aggregate-carrying-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cost-of-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/costmethod-investments-other-than-temporary-impairment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/costs-and-expenses https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/current-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/current-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-carrying-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-convertible-effective-interest-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-convertible-threshold-percentage-of-stock-price-trigger https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-face-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-fair-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-periodic-payment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-periodic-payment-principal https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-repaid https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-unamortized-discount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/debt-unamortized-discount-premium-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deconsolidation-revaluation-of-retained-investment-gain-or-loss-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-finance-costs-current-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-finance-costs-noncurrent-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-income-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-offering-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-rent-credit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-revenue-2 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-derivative-instruments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-equity-method-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-tax-credit-carryforwards-foreign https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-goodwill https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/depreciation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/depreciation-and-amortization https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/derivative-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/derivative-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/derivative-liability-measurement-input https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/diluted-shares https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/direct-costs-of-hotels https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-accounts-notes-and-loans-receivable-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-accounts-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-accounts-payable-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-cash-and-cash-equivalents https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-depreciation-and-amortization https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-general-and-administrative-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-goodwill https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-interest-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-inventory https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-inventory-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-operating-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-other-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-other-current-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-other-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-other-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-other-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-prepaid-and-other-assets-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/distribution-made-to-limited-partner-cash-distributions-paid https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/dividends-declared https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/due-from-related-parties-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/due-to-related-parties-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/effective-tax-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/entity-listing-par-value-per-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/eps https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/eps-basic https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-aggregate-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-dividends-or-distributions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-current-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-current-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-equity-or-capital https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-gross-profit-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-income-loss-from-before-extraordinary-items https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-liabilities-and-equity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-net-income-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-noncurrent-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investment-summarized-financial-information-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-method-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/equity-securities-fv-ni-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/escrow-deposit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fees-and-commissions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/financing-cash-flow https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/foreign-earnings https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/form-d-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/franchise-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/fresh-start-adjustment-increase-decrease-deferred-income-tax-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/gain-loss-on-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/goodwill https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/goodwill-acquired https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/goodwill-translation-adjustments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/impairment-charge-on-reclassified-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-before-extraordinary-items-and-cumulative-effect-of-change-in-accounting-principle https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-attributable-to-noncontrolling-entity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-operations-before-extraordinary-items-per-basic-and-diluted-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-taxes-paid https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-due-from-affiliates-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-prepaid-rent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/initial-franchise-fees https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-preferred https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-warrants https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-and-debt-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-and-other-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-expense-lessee-assets-under-capital-lease https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-expense-short-term-borrowings https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-income-expense-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-income-operating https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-income-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-paid https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-paid-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-payable-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/inventory https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/investing-cash-flow https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/investment-banking-advisory-brokerage-and-underwriting-fees-and-commissions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/investment-income-dividend https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/investment-income-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/labor-and-related-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/lease-and-rental-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/lease-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/legal-fees https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/level-3-liability-purchases-sales-issuances-settlements https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/level-3-liability-transfers-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/liabilities-assumed https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/liabilities-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/liabilities-subject-to-compromise https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/liabilities-subject-to-compromise-increase-decrease-in-other-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit-facility-average-outstanding-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit-facility-increase-decrease-for-period-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/line-of-credit-facility-periodic-payment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/lines-of-credit-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/litigation-settlement-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/litigation-settlement-amount-awarded-from-other-party https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/loans-payable-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/long-term-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/long-term-notes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/minority-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/minority-interest-change https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/minority-interest-decrease-from-distributions-to-noncontrolling-interest-holders https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/minority-interest-ownership-percentage-by-parent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-cash-from https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-change-in-cash https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncash-contribution-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncash-or-part-noncash-acquisition-debt-assumed https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncash-or-part-noncash-acquisition-other-assets-acquired https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncash-or-part-noncash-acquisition-value-of-liabilities-assumed https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/noncurrent-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/nonoperating-income-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/notes-and-loans-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/notes-payable-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/notes-payable-to-bank https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/number-of-operating-segments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/number-of-reportable-segments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/number-of-restaurants https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-available-for-sale-adjustment-before-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-available-for-sale-adjustment-net-of-tax-change https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-foreign-currency-translation-gain-loss-arising-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-reclassification-adjustment-from-aoci-on-derivatives-before-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/oci-tax https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-cash-flow https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-expenses https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-liability https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-after-rolling-year-five https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-additional-capital https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-current-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-expenses https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-long-term-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-noncash-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-nonoperating-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-operating-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-payments-to-acquire-businesses https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-receivables https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-receivables-net-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-sales-revenue-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net-available-for-sale-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-of-financing-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-to-acquire-additional-interest-in-subsidiaries https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-to-acquire-equipment-on-lease https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/payments-to-minority-shareholders https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/pre-opening-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-shares-facts https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-convertible-conversion-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-no-par-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-stock-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/preferred-units-offering-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/prepaid-expense-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/pretax-income https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-contributions-from-affiliates https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-equity-method-investment-dividends-or-distributions-return-of-capital https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-of-unsecured-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-loans https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-operating-activities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-repayments-of-other-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-sale-of-insurance-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-sale-of-other-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-sale-of-treasury-stock https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/professional-fees https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/profit-loss https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/property-plant-and-equipment-other-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/property-plant-equipment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/public-float https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/realized-gains-on-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/redeemable-noncontrolling-interest-equity-preferred-carrying-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/redeemable-preferred-stock-dividends https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-other-long-term-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/repayments-of-unsecured-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/research-and-development https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/research-and-development-in-process https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/restricted-cash-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/results-of-operations-income-before-income-taxes https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/retained-earnings https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/revenue-from-collaborative-arrangement-excluding-revenue-from-contract-with-customer https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/revenue-from-leased-and-owned-hotels https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/revenue-from-related-parties https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/revenues https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/royalty-revenue https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sales-revenue-net https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sales-revenue-services-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-1-e https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-10-k https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-10-q https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-10ksb https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-10qsb https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-15-12g https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-2-e https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-25-nse https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-40-17g https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-425 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-8-k https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-ars https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-certnas https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-def-14a https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-def-14c https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-defa14a https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-defm14a https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-n-54a https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-n-54c https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-prer14a https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-prer14c https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/sec-filings-s-4 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-aw https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secured-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/secured-debt-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/segment-reporting-information-investments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/segment-reporting-information-net-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/share-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/shareholders-equity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/shares-authorized https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/shares-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/shares-outstanding-2 https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/short-term-bank-loans-and-notes-payable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/short-term-borrowings https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/short-term-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/short-term-lease-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-non-option-equity-instruments-expirations https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-non-option-equity-instruments-forfeitures https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-based-compensation https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stock-split-ratio https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stockholders-equity-change https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stockholders-equity-note-stock-split-conversion-ratio https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-minority-interest-income-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/tax-reconciliation-tax-settlements-foreign https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/technology-services-costs https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/total-assets https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/total-liabilities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/total-long-term-debt https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/trading-securities-fair-value-disclosure https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/travel-and-entertainment-expense https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/treasury-stock-shares https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/treasury-stock-value https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/unbilled-receivables-current https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/undistributed-earnings https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/unrealized-loss-on-securities https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/value-added-tax-receivable https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/variable-lease-cost https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/sonnet-biotherapeutics-holdings-inc/weighted-average-number-of-share-outstanding-basic-and-diluted